State of Wisconsin Investment Board Portfolio holdings
AUM
$40.9B
1-Year Return
24.31%
This Quarter Return
+4.87%
1 Year Return
+24.31%
3 Year Return
+99.94%
5 Year Return
+177.86%
10 Year Return
+427.44%
AUM
$35.9B
AUM Growth
+$692M
(+2%)
Cap. Flow
-$609M
Cap. Flow
% of AUM
-1.7%
Top 10 Holdings %
Top 10 Hldgs %
16.09%
Holding
1,660
New
123
Increased
661
Reduced
730
Closed
128
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
+$183M |
| 2 |
HCA Healthcare
HCA
|
+$115M |
| 3 |
AGN
Allergan plc
AGN
|
+$108M |
| 4 |
Willis Towers Watson
WTW
|
+$103M |
| 5 |
Parker-Hannifin
PH
|
+$99.2M |
Top Sells
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$168M |
| 2 |
Apple
AAPL
|
+$89.4M |
| 3 |
Microsoft
MSFT
|
+$86.5M |
| 4 |
Johnson & Johnson
JNJ
|
+$79.1M |
| 5 |
JPMorgan Chase
JPM
|
+$68M |
Sector Composition
| 1 | Technology | 17.85% |
| 2 | Financials | 16.67% |
| 3 | Healthcare | 13.41% |
| 4 | Consumer Discretionary | 10.38% |
| 5 | Industrials | 10.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RUBY
1201
DELISTED
Rubius Therapeutics, Inc
RUBY
| $780K | ﹤0.01% |
49,600
+33,300
| +204% | +$524K |
|
|
NATI
1202
DELISTED
National Instruments Corp
NATI
| $779K | ﹤0.01% |
18,561
-2,053
| -10% | -$86.2K |
|
1203
First Solar
FSLR
$21.6B
| $770K | ﹤0.01% |
11,730
-3,556
| -23% | -$233K |
|
1204
Supernus Pharmaceuticals
SUPN
$2.55B
| $768K | ﹤0.01% |
23,200
-42,000
| -64% | -$1.39M |
|
1205
Wave Life Sciences
WVE
$1.11B
| $764K | ﹤0.01% |
29,300
+6,000
| +26% | +$156K |
|
1206
Travel + Leisure Co
TNL
$4.02B
| $762K | ﹤0.01% |
17,350
-4,665
| -21% | -$205K |
|
|
DHC
1207
Diversified Healthcare Trust
DHC
$1.07B
| $761K | ﹤0.01% |
92,025
+48,032
| +109% | +$397K |
|
|
QD
1208
Qudian
QD
$707M
| $759K | ﹤0.01% |
+101,157
| New | +$759K |
|
|
SRCL
1209
DELISTED
Stericycle Inc
SRCL
| $759K | ﹤0.01% |
15,904
-2,730
| -15% | -$130K |
|
1210
Allison Transmission
ALSN
$7.39B
| $758K | ﹤0.01% |
16,349
-5,068
| -24% | -$235K |
|
1211
Kemper
KMPR
$3.35B
| $755K | ﹤0.01% |
+8,750
| New | +$755K |
|
1212
Twin Disc
TWIN
$187M
| $755K | ﹤0.01% |
50,000
| – | – |
|
1213
New York Times
NYT
$9.59B
| $754K | ﹤0.01% |
+23,111
| New | +$754K |
|
1214
Cullen/Frost Bankers
CFR
$8.2B
| $753K | ﹤0.01% |
8,041
-2,560
| -24% | -$240K |
|
1215
Synovus
SNV
$7.18B
| $752K | ﹤0.01% |
21,473
-8,477
| -28% | -$297K |
|
1216
Hanover Insurance
THG
$6.45B
| $743K | ﹤0.01% |
5,795
-2,121
| -27% | -$272K |
|
1217
TG Therapeutics
TGTX
$5.1B
| $742K | ﹤0.01% |
85,800
+1,900
| +2% | +$16.4K |
|
|
ZNGA
1218
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $742K | ﹤0.01% |
120,993
-21,675
| -15% | -$133K |
|
1219
Popular Inc
BPOP
$8.34B
| $738K | ﹤0.01% |
13,601
-4,842
| -26% | -$263K |
|
1220
Bruker
BRKR
$4.69B
| $738K | ﹤0.01% |
14,779
-3,988
| -21% | -$199K |
|
1221
Madison Square Garden
MSGS
$5.12B
| $738K | ﹤0.01% |
3,694
-1,149
| -24% | -$230K |
|
|
EIDX
1222
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $737K | ﹤0.01% |
23,700
+13,800
| +139% | +$429K |
|
|
IAA
1223
DELISTED
IAA, Inc. Common Stock
IAA
| $735K | ﹤0.01% |
+18,943
| New | +$735K |
|
1224
Cable One
CABO
$968M
| $730K | ﹤0.01% |
623
-178
| -22% | -$209K |
|
1225
EQT Corp
EQT
$31.8B
| $727K | ﹤0.01% |
45,993
-11,085
| -19% | -$175K |
|